Logo of The Journal of Bone & Joint Surgery (Br)
Quick search:        
          Advanced Search
Guest Access | Sign In
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skripitz, R.
Right arrow Articles by Aspenberg, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skripitz, R.
Right arrow Articles by Aspenberg, P.

Parathyroid hormone (1-34) increases the density of rat cancellous bone in a bone chamber

A DOSE-RESPONSE STUDY

R. Skripitz, MD, Research Assistant1; T. T. Andreassen, MD, PhD, Associate Professor2; and P. Aspenberg, MD, PhD, Associate Professor1

1 Department of Orthopaedics, Lund University Hospital, S-22185 Lund, Sweden.
2 Department of Connective Tissue Biology, Institute of Anatomy, University of Aarhus, DK-8000 Aarhus, Denmark.

Correspondence should be sent to Dr P. Aspenberg.

Intermittent treatment with parathyroid hormone (PTH) has an anabolic effect on both intact cancellous and cortical bone. Very little is known about the effect of the administration of PTH on the healing of fractures or the incorporation of orthopaedic implants. We have investigated the spontaneous ingrowth of callus and the formation of bone in a titanium chamber implanted at the medioproximal aspect of the tibial metaphysis of the rat. Four groups of ten male rats weighing approximately 350 g were injected with human PTH (1-34) in a dosage of 0, 15, 60 or 240 µg/kg/day, respectively, for 42 days from the day of implantation of the chamber.

During the observation period the chamber became only partly filled with callus and bone and no difference in ingrowth distance into the chamber was found between the groups. The cancellous density was increased by 90%, 132% and 173% in the groups given PTH in a dosage of 15, 60 or 240 µg/kg/day, respectively. There was a linear correlation between bone density and the log PTH doses (r2= 0.6).

Our findings suggest that treatment with PTH may have a potential for enhancement of the incorporation of orthopaedic implants as well as a beneficial effect on the healing of fractures when it is given in low dosages.




This article has been cited by other articles:


Home page
J Bone Joint Surg BrHome page
H. R. Johansson, R. Skripitz, and P. Aspenberg
Bisphosphonates can block the deterioration in implant fixation after withdrawal of intermittent doses of parathyroid hormone
J Bone Joint Surg Br, March 1, 2008; 90-B(3): 400 - 404.
[Abstract] [Full Text] [PDF]



(c) British Editorial Society of Bone and Joint Surgery All Rights Reserved
Registered charity no: 209299     Print ISSN: 0301-620X
Hip, Knee, Trauma, Upper limb, Foot & Ankle, Paediatrics, Oncology, Spine, Arthroplasty, General